Researchers in Japan have found the Lambda COVID-19 variant exhibits higher infectivity and immune resistance to vaccines than the version of the virus that first emerged in Wuhan, China.
A recently published preprint of a Japanese study, which has yet to be peer-reviewed, suggests said the Lambda variant, first detected in Peru, is able to resist vaccine-induced neutralizing antibodies that can fight off the CCP (Chinese Communist Party) virus.
